MOH — authorised 6 May 1946
- Marketing authorisation holder: AKORN
- Status: likely_approved
MOH authorised Bal on 6 May 1946
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 6 May 1946.
AKORN holds the UAE marketing authorisation.